Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Apr;74(4):459-61.
doi: 10.1136/jnnp.74.4.459.

Recanalisation of cerebral venous thrombosis

Affiliations
Clinical Trial

Recanalisation of cerebral venous thrombosis

R W Baumgartner et al. J Neurol Neurosurg Psychiatry. 2003 Apr.

Abstract

Objective: To investigate recanalisation in the first 12 months after cerebral venous thrombosis.

Methods: 33 consecutive patients presenting with cerebral venous thrombosis were enrolled in the study. Diagnosis was made by magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) or catheter angiography. Patients were initially treated with intravenous heparin. Warfarin was given for at least four months. Cerebral MRI and MRV were done at four months and repeated after 12 months if venous thrombosis persisted. Outcome was evaluated by the Rankin scale at 12 months.

Results: Outcome at 12 months was good, with a median modified Rankin scale score of 0 (range 0 to 2); 27 patients (82%) had no residual deficits. No patient suffered recurrent cerebral venous thrombosis, deep vein thrombosis, or pulmonary embolism during follow up. After four months, all deep cerebral veins and cavernous sinuses, 94% of superior sagittal sinuses, 80% of straight sinuses, 73% of jugular veins, 58% of transverse sinuses, and 41% of sigmoid sinuses had recanalised. No further recanalisation was observed thereafter.

Conclusions: The results suggest that recanalisation only occurs within the first four months following cerebral venous thrombosis and not thereafter, irrespective of oral anticoagulation.

PubMed Disclaimer

References

    1. Stroke. 1988 May;19(5):604-7 - PubMed
    1. Neurology. 1990 May;40(5):813-5 - PubMed
    1. Radiology. 1991 Feb;178(2):453-8 - PubMed
    1. Lancet. 1991 Sep 7;338(8767):597-600 - PubMed
    1. Stroke. 1999 Mar;30(3):484-8 - PubMed

Publication types

MeSH terms